Trial Details
COMPLETEDBasic Information
| Clinical ID | c709 |
|---|---|
| Identifier | NCT00336492 |
| Trial Title | A Study of the Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Patients With Moderately to SeverelyActive Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | BIOLOGICAL: infliximab|BIOLOGICAL: infliximab|BIOLOGICAL: infliximab|BIOLOGICAL: infliximab |
Participant Information
| Sponsor | Centocor, Inc. |
|---|---|
| City | Birmingham |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-09-06 |
|---|---|
| Primary Completion Date | 2025-05-09 |
| Completion Date | 2025-04-10 |